Why is Vimta Labs falling/rising?

As of 06-Nov, Vimta Labs Ltd is experiencing a decline in its stock price, currently at Rs 621.95, which reflects a decrease of Rs 39.4 or 5.96%. The stock has underperformed its sector by 2.78% today and has been on a consecutive downward trend for the last three days, resulting in a total drop of 14.24% during this period. Despite this recent decline, the stock has shown impressive long-term growth, with a 113.36% increase over the past year, significantly outperforming the market benchmark. The company has reported strong financials, including a low debt-to-equity ratio and consistent positive operating results, which contribute to its overall healthy long-term growth outlook.
In the broader market context, Vimta Labs' short-term performance has been notably weaker than the benchmark, with a 1-week return of -13.11% compared to the Sensex's -1.30%. This underperformance is compounded by a sector-wide decline of 3.23% in Medical Equipment/Supplies/Accessories. However, the stock has shown resilience in the long term, with a year-to-date return of 25.02%, which is still favorable compared to the Sensex's 6.62%. The recent increase in investor participation, indicated by a 47.87% rise in delivery volume, suggests that there may be underlying confidence in the stock despite its current price decline.